Alloy Therapeutics stock

Alloy Therapeutics Stock

HealthTech

Looking to sell Alloy Therapeutics stock or options?

Founded: 2020Funding to Date: $136Mhttps://www.alloytx.com

Alloy Therapeutics has developed a drug discovery platform designed to support and expedite antibody discovery projects. The company's innovative technology includes humanized transgenic antibody discovery, which offers wide, non-exclusive access to drug discovery tools. This empowers scientists to carry out their antibody projects without any difficulty.

Investors Include:

Tony Eng, Massachusetts Life Sciences Center, Jesse Robbins, Founders Fund, Calm Ventures, 8VC, 10X Capital, Alexandria Venture Investments, Jonathan Harshman, Luma Bio-IT Management, New Silk Route Growth Capital, Thiel Capital, Adam Groff, Ulysses Diversified Holding, Gaingels, Kent Mabalay, OurCrowd, Peter Thiel, Mubadala Capital, Presight Capital.

Collective explained in 2 minutes

Learn how Collective's solutions enable you to manage your risk and maximize your wealth

Learn more